Spacex Hosts First Earnings Call: Is It a Buy Now?
SpaceX finally faces the public market with its first earnings call after the IPO. This guide breaks down what invest...
This article outlines scenarios where target date funds may be preferable to index funds in a 401(k), focusing on simplicity and risk management.
26,105 articlesSpaceX finally faces the public market with its first earnings call after the IPO. This guide breaks down what invest...
As Semtech gears up for its 2026 results, investors want concrete takeaways on growth drivers, margins, and capital d...
After a strong rally, investors ask if AMD remains a smart bet. This in-depth look weighs AI roadmaps, growth drivers...
With SpaceX poised to hit the public markets, a wave of megadeals led by Elon Musk looms. Analysts warn the IPO could...
When a founder sells a large chunk of stock, it can raise questions for investors. This article explains what best bu...
Geopolitical tensions involving Iran can shift the defense landscape fast. This guide explains how to spot potential ...
A couple retiring at 62 with $1.6 million must navigate a roughly $96,000 healthcare gap before Medicare kicks in, pr...
SpaceX's IPO hype is hard to ignore, but there are four solid concerns investors should weigh before buying in. This ...
A Hong Kong-based stablecoin payments processor plans a $150 million pre-IPO round to fuel a possible U.S. listing th...
PepsiCo beat expectations in Q1 with revenue rising 8.5% and earnings surpassing estimates. International momentum an...
Markets crave clarity, and headlines about potential peace with Iran surface repeatedly. This guide explains what to ...
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...